NCT04538391View on ClinicalTrials.gov

Intra Incisional Infiltration of Bupivacaine Versus Meloxicam on Post Cesarean Section Pain Relief

NACompletedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

March 3, 2019

Primary Completion Date

March 5, 2020

Study Completion Date

May 9, 2020

Conditions
Cesarean Section Pain
Interventions
DRUG

local ifiltration Bupivacaine, Meloxican and placebo

no other intervention done

Trial Locations (1)

11111

Menoufia University hospital, Shibīn al Kawm

All Listed Sponsors
lead

Menoufia University

OTHER

NCT04538391 - Intra Incisional Infiltration of Bupivacaine Versus Meloxicam on Post Cesarean Section Pain Relief | Biotech Hunter | Biotech Hunter